Susan Hertzberg, a senior healthcare executive with extensive experience building successful companies in both life sciences and consumer healthcare, will serve as Prelude Fertility’s Chief Executive Officer. With over 25 years of diversified strategic and results-oriented experience in healthcare. Hertzberg most recently acted as the CEO and President of Boston Heart Diagnostics. As CEO of Prelude, Hertzberg will manage the network expansion of fertility clinics and advance the company’s goal of radically improving fertility choices, care, and outcomes. As the CEO of Boston Heart Diagnostics, Hertzberg led the company out of the start-up phase and increased the company’s annual revenue by over 4,650%. She also helped oversee staff expansion to 400 employees from 38. Prior to Boston Heart Diagnostics, she served as the Chief Operating Officer at Ipsogen Inc. from 2008 to 2010, which was soon acquired by Quagen Inc. In 2014, she was a regional winner and national finalist of Ernst & Young’s Entrepreneur Of The Year™. She currently serves on the Affiliate Board of the American Heart Association and the Board of Directors for BreastCancer.org. Hertzberg earned her MBA from Columbia University. She currently resides in New York City.